Publication: TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species
Authors
Roca Soler, Francisco José ; Ramakrishnan, Lalita
item.page.secondaryauthor
item.page.director
Publisher
Cell Press
publication.page.editor
publication.page.department
DOI
https://doi.org/10.1016/j.cell.2013.03.022
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Tumor necrosis factor (TNF) constitutes a critical host defense against tuberculosis, but its excess is also implicated in tuberculosis pathogenesis in zebrafish and humans. Using the zebrafish, we elucidate the pathways by which TNF mediates tuberculosis pathogenesis. TNF excess induces mitochondrial reactive oxygen species (ROS) in infected macrophages through RIP1-RIP3-dependent pathways. While initially increasing macrophage microbicidal activity, ROS rapidly induce programmed necrosis (necroptosis) and release mycobacteria into the growth-permissive extracellular milieu. TNF-induced necroptosis occurs through two pathways: modulation of mitochondrial cyclophilin D, implicated in mitochondrial permeability transition pore formation, and acid sphingomyelinase-mediated ceramide production. Combined genetic blockade of cyclophilin D and acid sphingomyelinase renders the high TNF state hyperresistant by preventing macrophage necrosis while preserving increased microbicidal activity. Similarly, the cyclophilin D-inhibiting drug alisporivir and the acid sphingomyelinase-inactivating drug, desipramine, synergize to reverse susceptibility, suggesting the therapeutic potential of these orally active drugs against tuberculosis and possibly other TNF-mediated diseases.
publication.page.subject
Citation
Cell 153, 521–534, April 25, 2013
item.page.embargo
Collections
Ir a Estadísticas
Sin licencia Creative Commons.